Standard

Medication use (HMG CoA reductase inhibitors)

ACVRL1 · rs2293093

Where this position leads

Condition: Medication Use as a Genetic Trait

rs2293093 Condition: Medication Use as a Genetic Trait Medication Use as a Genetic Trait Condition rs2293093 rs2293093 ACVRL1

What the study found

Who was studied 73,475 European ancestry cases, 216,910 European ancestry controls.

The effect Each copy of the G allele shifted the measure 0.0512 higher (95% confidence interval 0.034-0.069); p = 9 × 10−9.

How common The G allele had a frequency of about 11% in the people studied.

Where it sits Chromosome 12, band 12q13.13 — in the 3′ untranslated region of ACVRL1.

What ClinVar records

Classification Benign for Telangiectasia, hereditary hemorrhagic, type 2; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 2 submitters), last evaluated 2018-01-13. ClinVar record 309483 NM_000020.3(ACVRL1):c.*2380C>G

What this is ClinVar's aggregate record for this position (as of its 2026-09-24 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

What each result means

C/C Published research associates this genotype with typical/baseline likelihood of Medication use (HMG CoA reductase inhibitors) — no copies of the reported risk allele.
C/G Published research associates this genotype (one copy of the reported risk allele) with an intermediate association with Medication use (HMG CoA reductase inhibitors).
G/G Published research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Medication use (HMG CoA reductase inhibitors) compared to the general population.
Source

Questions about rs2293093

What is rs2293093?

rs2293093 is a single position in the genome, in or near the ACVRL1 gene. Published research associates it with medication use (hmg coa reductase inhibitors). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs2293093 linked to?

On MyGeneLog this position is linked to Medication Use as a Genetic Trait. The research behind each link, and its sources, are set out on that condition page.

Does having rs2293093 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs2293093 come from?

GWAS Catalog, Nat Commun 2019, PMID:31015401. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Medication use (HMG CoA reductase inhibitors) (rs2293093). MyGeneLog™. https://www.mygenelog.com/variants/rs2293093

← See all variants